Related Experiment Video
Updated: May 4, 2026

Isolation of Mouse Megakaryocyte Progenitors
Published on: May 20, 2021
Rho kinase inhibition drives megakaryocyte polyploidization and proplatelet formation through MYC and NFE2
Mauro P Avanzi1, Francine Goldberg, Jennifer Davila
1Platelet Biology Laboratory, Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, USA; Cellular Therapy Laboratory, Hematology Division, Santa Casa Medical School, São Paulo, Brazil.
Abstract:
The processes of megakaryocyte polyploidization and demarcation membrane system (DMS) formation are crucial for platelet production, but the mechanisms controlling these processes are not fully determined. Inhibition of Rho kinase (ROCK) signalling leads to increased polyploidization in umbilical cord blood-derived megakaryocytes. To extend these findings we determined the effect of ROCK inhibition on development of the DMS and on proplatelet formation. The underlying mechanisms were explored by analysing the effect of ROCK inhibition on the expression of MYC and NFE2, which encode two transcription factors critical for megakaryocyte development. ROCK inhibition promoted DMS formation, and increased proplatelet formation and platelet release. Rho kinase inhibition also downregulated MYC and NFE2 expression in mature megakaryocytes, and this down-regulation correlated with increased proplatelet formation. Our findings suggest a model whereby ROCK inhibition drives polyploidization, DMS growth and proplatelet formation late in megakaryocyte maturation through downregulation of MYC and NFE2 expression.
Insights
Inhibiting Rho kinase (ROCK) signaling boosts megakaryocyte polyploidization and platelet production by promoting the demarcation membrane system (DMS) and downregulating MYC and NFE2 expression.
Area of Science:
- Hematology
- Cell Biology
- Molecular Biology
Background:
- Megakaryocyte polyploidization and demarcation membrane system (DMS) formation are essential for platelet production.
- The precise molecular mechanisms governing these processes remain incompletely understood.
Purpose of the Study:
- To investigate the impact of Rho kinase (ROCK) inhibition on DMS development and proplatelet formation in megakaryocytes.
- To elucidate the underlying molecular mechanisms, focusing on the expression of transcription factors MYC and NFE2.
Main Methods:
- Utilized umbilical cord blood-derived megakaryocytes.
- Administered ROCK inhibitors.
- Assessed DMS formation, proplatelet formation, and platelet release.
- Quantified MYC and NFE2 gene expression in mature megakaryocytes.
Main Results:
- ROCK inhibition significantly enhanced DMS formation.
- Proplatelet formation and subsequent platelet release were increased following ROCK inhibition.
- ROCK inhibition led to the downregulation of MYC and NFE2 expression in mature megakaryocytes.
- Downregulation of MYC and NFE2 correlated positively with enhanced proplatelet formation.
Conclusions:
- ROCK inhibition promotes megakaryocyte polyploidization, DMS expansion, and proplatelet formation.
- These effects are mediated, at least in part, by the downregulation of MYC and NFE2 transcription factors late in megakaryocyte maturation.
Related Concept Videos
MAPK Signaling Cascades
Mitogens and the Cell Cycle
PI3K/mTOR/AKT Signaling Pathway
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Receptor Tyrosine Kinases
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

